Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Esophageal Squamous Cell Carcinoma
×
Levoleucovorin
×
Clear all
Filters
3
NCT04949256
2025-12-15
MK-7902-014
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
864 enrolled
NCT04210115
2024-11-15
KEYNOTE 975
Merck Sharp & Dohme LLC
Phase 3
Active not recruiting
703 enrolled